Hood River Capital Management LLC Krystal Biotech, Inc. Transaction History

Hood River Capital Management LLC

  • $5.79 Billion
  • Q4 2024

A detailed history of Hood River Capital Management LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Hood River Capital Management LLC holds 512,726 shares of KRYS stock, worth $96.3 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
512,726
Previous 502,104 2.12%
Holding current value
$96.3 Million
Previous $91.3 Million 12.03%
% of portfolio
1.39%
Previous 1.69%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$156.64 - $199.61 $1.66 Million - $2.12 Million
10,622 Added 2.12%
512,726 $80.3 Million
Q3 2024

Nov 14, 2024
SELL
$174.7 - $213.66 $3.32 Million - $4.06 Million
-18,989 Reduced 3.64%
502,104 $91.3 Million
Q2 2024

Aug 14, 2024
BUY
$153.12 - $183.64 $3.91 Million - $4.68 Million
25,507 Added 5.15%
521,093 $95.7 Million
Q1 2024

May 15, 2024
BUY
$108.01 - $179.35 $4 Million - $6.65 Million
37,073 Added 8.09%
495,586 $88.2 Million
Q4 2023

Feb 14, 2024
SELL
$96.0 - $128.29 $189,696 - $253,501
-1,976 Reduced 0.43%
458,513 $56.9 Million
Q3 2023

Nov 14, 2023
BUY
$108.51 - $130.22 $871,660 - $1.05 Million
8,033 Added 1.78%
460,489 $53.4 Million
Q2 2023

Aug 14, 2023
BUY
$78.48 - $130.32 $397,344 - $659,810
5,063 Added 1.13%
452,456 $53.1 Million
Q1 2023

May 15, 2023
BUY
$72.39 - $84.27 $1.49 Million - $1.73 Million
20,514 Added 4.81%
447,393 $35.8 Million
Q4 2022

Feb 14, 2023
BUY
$63.14 - $79.9 $639,166 - $808,827
10,123 Added 2.43%
426,879 $33.8 Million
Q3 2022

Nov 14, 2022
BUY
$64.85 - $82.4 $502,263 - $638,188
7,745 Added 1.89%
416,756 $29 Million
Q2 2022

Aug 15, 2022
BUY
$48.93 - $73.47 $1.18 Million - $1.78 Million
24,201 Added 6.29%
409,011 $26.9 Million
Q1 2022

May 16, 2022
BUY
$51.99 - $72.11 $8.27 Million - $11.5 Million
159,083 Added 70.48%
384,810 $25.6 Million
Q4 2021

Feb 14, 2022
SELL
$39.81 - $88.24 $6,926 - $15,353
-174 Reduced 0.08%
225,727 $15.8 Million
Q3 2021

Nov 15, 2021
SELL
$52.01 - $71.77 $461,120 - $636,312
-8,866 Reduced 3.78%
225,901 $11.8 Million
Q2 2021

Aug 13, 2021
SELL
$62.14 - $81.82 $193,566 - $254,869
-3,115 Reduced 1.31%
234,767 $16 Million
Q1 2021

May 17, 2021
SELL
$59.42 - $85.46 $1.38 Million - $1.99 Million
-23,240 Reduced 8.9%
237,882 $18.3 Million
Q4 2020

Feb 16, 2021
BUY
$40.64 - $61.38 $159,268 - $240,548
3,919 Added 1.52%
261,122 $15.7 Million
Q3 2020

Nov 16, 2020
SELL
$37.76 - $48.49 $944,302 - $1.21 Million
-25,008 Reduced 8.86%
257,203 $11.1 Million
Q2 2020

Aug 14, 2020
BUY
$37.03 - $60.0 $10.5 Million - $16.9 Million
282,211 New
282,211 $11.7 Million

Others Institutions Holding KRYS

# of Institutions
299
Shares Held
24.3M
Call Options Held
388K
Put Options Held
233K
View Full List

About Krystal Biotech, Inc.

KRYS Quotes by TradingView
  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.82B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Hood River Capital Management LLC Portfolio

Follow Hood River Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hood River Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hood River Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email